<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Disturbances of erythrocyte and placental membrane functiond have been studied in placenta of pregnant women with <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> type 2 </plain></SENT>
<SENT sid="1" pm="."><plain>The results of this study demonstrate significant metabolic impairments in women with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Changes in <z:chebi fb="23" ids="18059">lipid</z:chebi> spectrum of erythrocyte membranes and decreased activity of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes obviously contribute to the development of fetoplacental insufficiency </plain></SENT>
<SENT sid="3" pm="."><plain>This changes point to necessity of the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> therapy in pregnant women with <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> type 2 </plain></SENT>
</text></document>